AstraZeneca AZN.L
🇬🇧 United Kingdom• FTSE100
£132.00£2.62 (-1.95%)
Market Closed | Last updated: 2:32:10 AM
Key Statistics
| Metric | Value |
|---|---|
| Market Cap | 204.7B |
| P/E Ratio | 26.7 |
| EPS | £0.05 |
| Beta | 0.21 |
| 52-Week High | £157.32 |
| 52-Week Low | - |
| Volume | 1 |
| Avg Volume | 2.2M |
| Dividend Yield | 1.79% |
| Annual Dividend | £0.0236 |
| Ex-Dividend Date | 2026-02-19 |
| Payout Ratio | - |
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for oncology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: www.astrazeneca.com
Employees: 96,100
Analyst Rating: BUY
Target Price: £164.97
Performance Summary
| Period | Performance | Change |
|---|---|---|
| 1 Week | -3.17% | £4.32 |
| 1 Month | -3.72% | £5.10 |
| 3 Months | -7.54% | £10.76 |
| 6 Months | -2.57% | £3.48 |
| 1 Year | +22.02% | +£23.82 |
| Year to Date | -4.28% | £5.90 |
Dividend History
| Ex-Date | Amount |
|---|---|
| 2026-02-19 | £1.5950 |
| 2025-08-07 | £0.7670 |
| 2025-02-20 | £1.6800 |
| 2024-08-08 | £0.7760 |
| 2024-02-22 | £1.5600 |
| 2023-08-10 | £0.7180 |
| 2023-02-23 | £1.6280 |
| 2022-08-11 | £0.7640 |
| 2022-02-24 | £1.4530 |
| 2021-08-12 | £0.6480 |
Estimated annual dividend: £2.3620
Community Discussion
No posts about $AZN yet. Be the first!